← Leaderboards
Pengfei Wang
University Of Alabama At Birmingham
$1,722,015
Attributed
$1,722,015
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $452.5K · FY2012–20$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,722,015 · 3
By mechanism
R01$1,178,868 · 1
R21$396,647 · 1
R03$146,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert Floyd Pass$10,874,670
- Janet L Yother$8,695,295
- Suzanne M. Michalek$6,713,138
- James J Kobie$11,682,706
- Luis Martinez-Sobrido$6,855,646
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignAdjuvantVaccine Clinical TrialVaccinesEmerging Communicable DiseasesSubunit VaccinesSaponinsToxic EffectEvaluationNovel VaccinesMalignant NeoplasmsCommunicable DiseasesDose-LimitingBaseAntigensImmune ResponseChemical StabilityAdjuvanticityDrug IndustryAnalogFormulationResponseMolecularClinical Trials
Grant awards (9)
Development of Structurally Defined Synthetic Vaccine Adjuvants$284,294
R01 · FY2020 · GM · contact PI
Development of Structurally Defined Synthetic Vaccine Adjuvants$284,294
R01 · FY2019 · GM · contact PI
Development of Structurally Defined Synthetic Vaccine Adjuvants$271,559
R01 · FY2018 · GM · contact PI
Development of Structurally Defined Synthetic Vaccine Adjuvants-equip sup$70,000
R01 · FY2018 · GM · contact PI
Development of Structurally Defined Synthetic Vaccine Adjuvants$268,721
R01 · FY2017 · GM · contact PI
Development of Structurally Defined QS-17/18-Based Vaccine Adjuvants$183,750
R21 · FY2017 · AI · contact PI
Development of Structurally Defined QS-17/18-Based Vaccine Adjuvants$212,897
R21 · FY2016 · AI · contact PI
DESIGN AND SYNTHESIS OF STRUCTURALLY DEFINED QS-21-BASED SYNTHETIC ADJUVANTS$73,250
R03 · FY2013 · AI · contact PI
DESIGN AND SYNTHESIS OF STRUCTURALLY DEFINED QS-21-BASED SYNTHETIC ADJUVANTS$73,250
R03 · FY2012 · AI · contact PI